A guru never calls himself a guru

Published September 20, 2021

ShareLab adds Lab Lead and entrepreneur-in-residence to the team

As of this month, the ShareLab team has been expanded with a new member: Tor Espen Stav-Noraas has a PhD in immunology and comes with several years of biotech experience from Thermo Fisher Scientific. He will take a leading role in moving ShareLab’s lab facilities and services to the next level, as well as assume the role of entrepreneur-in-residence.

Says Tor Espen “I love early discovery with a clear perception of the end-product in mind”. Cell therapy was Tor Espen’s key field at Thermo, while academic years were spent studying IL-33 and Notch pathways.

“The combination of his academic and industrial experience will no doubt be of great value to ShareLab members”, comments Esben A. Nilssen, managing partner at ShareLab, before continuing, “he will also help develop ideas into new biotech start-ups as part of his role as an entrepreneur-in-residence”.

We believe Tor Espen is our new biotech guru. Mind you, a guru would never call himself a guru.